QHSLab, Inc. releases December 2025 corporate presentation

QHSLab, Inc. filed a Form 8-K to announce that it has made its December 2025 corporate presentation available to the public.

Accepted by SEC EDGAR 12/01/2025 - 08:30 AM EST

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

QHSLab, Inc. filed a Form 8-K to announce that it has made its December 2025 corporate presentation available to the public. The presentation, dated December 1, 2025, provides information about the company’s business and operations and is included as Exhibit 99.1.

The disclosure is made under Regulation FD, which is intended to ensure that important company information is shared broadly and not selectively. QHSLab states that the information in this report and the exhibit is being furnished, not filed, meaning it is not subject to certain liability provisions. The company also highlights that investors and others can access potentially material information through its website, press releases, and social media channels, including Twitter, LinkedIn, Facebook, and Instagram.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did QHSLab, Inc. (USAQ) report in its latest Form 8-K?

QHSLab, Inc. furnished its December 2025 corporate presentation as part of a Form 8-K. The presentation, dated December 1, 2025, discusses the company’s business and operations and is attached as Exhibit 99.1.

What is the purpose of the December 2025 corporate presentation from QHSLab (USAQ)?

The December 2025 corporate presentation is intended to provide an overview of QHSLab’s business and operations. It is shared under Regulation FD to ensure broad, simultaneous access to information for investors and the public.

Is the information in QHSLab’s December 2025 presentation considered filed with the SEC?

No. QHSLab states that the information in this Form 8-K and the attached presentation is furnished under Item 7.01 of Regulation FD and is not deemed to be filed for purposes of Section 18 of the Exchange Act.

Where can investors find additional information about QHSLab, Inc. (USAQ)?

QHSLab indicates that investors can find public information on its website (https://usaqcorp.com), in press releases, and on social media channels including Twitter, LinkedIn, Facebook, and Instagram, where certain information could be deemed material.

Which exhibit in the QHSLab (USAQ) Form 8-K contains the December 2025 presentation?

Exhibit 99.1 to the Form 8-K contains QHSLab’s December 2025 corporate presentation, which was made available on December 1, 2025.

What SEC item does QHSLab use for this disclosure in the Form 8-K?

The disclosure is made under Item 7.01, Regulation FD Disclosure, which is used to provide broadly accessible updates about the company’s business and operations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): December 1, 2025

QHSLab, Inc.

(Exact Name of Registrant as Specified in its Charter)

0-19041

(Commission File No.)

Nevada		30-1104301
(State of Incorporation)		(I.R.S. Employer Identification No.)

901 Northpoint Parkway Suite 302 West Palm Beach FL 33407		33407
(Address of Principal Executive Offices)		(ZIP Code)

Registrant’s telephone number, including area code: (929) 379-6503

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Securities registered pursuant to Section 12(g) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value		USAQ		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

Pursuant to Regulation FD, QHSLab, Inc. (the “Company”) hereby furnishes its December 2025 Corporate Presentation (the “Presentation”), made available on December 1, 2025, regarding the Company’s business and operations. A copy of the Presentation is attached as Exhibit 99.1.

The information in this Current Report on Form 8-K (including the exhibit) is furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in the Report that is required to be disclosed solely by Regulation FD.

We do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any change in events, conditions, or circumstances on which any forward-looking statement is based.

By filing this Current Report on Form 8-K and furnishing the information contained herein, we make no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD. We use, and will continue to use, our website (https://usaqcorp.com), press releases, and various social media channels, including our Twitter account (https://twitter.com/qhslabinc), LinkedIn account (https://www.linkedin.com/company/65407282/admin/), Facebook account (https://www.facebook.com/QHSLabs and Instagram account (https://www.instagram.com/qhslabs/) as additional means of disclosing public information to investors, the media and others interested in the Company. It is possible that certain information we post on our website, disseminate in press releases and on social media could be deemed to be material information, and we encourage investors, the media and others interested in the Company to review the business and financial information that we post on our website, disseminate in press releases and on the social media channels identified above, as such information could be deemed to be material information.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits.

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

Exhibit No.		Description
99.1		Corporate Presentation made available on December 1, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this current report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 1, 2025

QHSLab, Inc.

	/s/ Troy Grogan
Name:	Troy Grogan
Title:	CEO and Chairman

Source: View Original Filing on SEC EDGAR